DNLI icon

Denali Therapeutics
DNLI

Overview Fund Activity

198 hedge funds and large institutions have $2.93B invested in Denali Therapeutics in 2022 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 86 increasing their positions, 52 reducing their positions, and 28 closing their positions.

Holders
198
Holders Change
-1
Holders Change %
-0.5%
% of All Funds
3.19%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
27
Increased
86
Reduced
52
Closed
28
Calls
$1.93M
Puts
$270K
Net Calls
+$1.66M
Net Calls Change
-$883K

Top Buyers

1
Wellington Management Group
1
Wellington Management Group
Massachusetts
$142M
2
Capital Research Global Investors
2
Capital Research Global Investors
California
$62.9M
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$277M
4
Temasek Holdings
4
Temasek Holdings
Singapore
$181M
5
DM
5
Deerfield Management
New York
$22.2M

Top Sellers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$1.79M
2
WP
2
Woodline Partners
California
$0
3
CM
3
Crestline Management
Texas
$191M
4
Morgan Stanley
4
Morgan Stanley
New York
$12M
5
Fidelity Investments
5
Fidelity Investments
Massachusetts
$61.6M
Name Market Value Shares Shares
Change 		Shares
Change %
Nomura Asset Management
226
Nomura Asset Management
Japan
– – – –
Group One Trading
227
Group One Trading
Illinois
– – – –
BTI
228
Blue Trust Inc
Georgia
$0 8 +2 +33%
VF
229
VitalStone Financial
Texas
$0 15 +15 New
6 7 8 9
10